Literature DB >> 16776432

Levodopa-induced alterations in speech rate in advanced Parkinson's disease.

Miet De Letter1, Patrick Santens, Marc De Bodt, Paul Boon, John Van Borsel.   

Abstract

The effect of speech rate on overall intelligibility in Parkinson's Disease (PD) is still a matter of debate. A comparison of the results of previous studies on speech rate in PD is hampered by methodological differences. In this study, we evaluated the effects of levodopa on speech rate and on its variability in a standardized reading task. Twenty-five patients were studied before and after levodopa administration while reading a standardized text. In accordance with previous studies, no significant improvement of speech rate was found. Rather an increased variability of speech rate in the on-medication state could be demonstrated. It is possible that this increased variability may be the consequence of respiratory deficits due to levodopa-induced dyskinesia or an increase of dysfluencies. However, the effects of defective auditory feedback and disturbed executive function cannot be ruled out.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16776432

Source DB:  PubMed          Journal:  Acta Neurol Belg        ISSN: 0300-9009            Impact factor:   2.396


  16 in total

1.  Evaluation of speech impairment in early stages of Parkinson's disease: a prospective study with the role of pharmacotherapy.

Authors:  Jan Rusz; Roman Cmejla; Hana Růžičková; Jiří Klempíř; Veronika Majerová; Jana Picmausová; Jan Roth; Evžen Růžička
Journal:  J Neural Transm (Vienna)       Date:  2012-07-08       Impact factor: 3.575

2.  Voice and fluency changes as a function of speech task and deep brain stimulation.

Authors:  Diana Van Lancker Sidtis; Tiffany Rogers; Violette Godier; Michele Tagliati; John J Sidtis
Journal:  J Speech Lang Hear Res       Date:  2010-07-19       Impact factor: 2.297

3.  Effects of Parkinson's Disease on Fundamental Frequency Variability in Running Speech.

Authors:  Leah K Bowen; Gabrielle L Hands; Sujata Pradhan; Cara E Stepp
Journal:  J Med Speech Lang Pathol       Date:  2013-09

4.  Speech-based characterization of dopamine replacement therapy in people with Parkinson's disease.

Authors:  R Norel; C Agurto; S Heisig; J J Rice; H Zhang; R Ostrand; P W Wacnik; B K Ho; V L Ramos; G A Cecchi
Journal:  NPJ Parkinsons Dis       Date:  2020-06-12

5.  Quantitative Analysis of Catecholamines in the Pink1 -/- Rat Model of Early-onset Parkinson's Disease.

Authors:  Cynthia A Kelm-Nelson; Michael A Trevino; Michelle R Ciucci
Journal:  Neuroscience       Date:  2018-02-27       Impact factor: 3.590

6.  Short- and long-term dopaminergic effects on dysarthria in early Parkinson's disease.

Authors:  Sabine Skodda; Wenke Visser; Uwe Schlegel
Journal:  J Neural Transm (Vienna)       Date:  2009-12-12       Impact factor: 3.575

7.  Reduction of dopamine synaptic activity: degradation of 50-kHz ultrasonic vocalization in rats.

Authors:  Michelle R Ciucci; Allison M Ahrens; Sean T Ma; Jacqueline R Kane; E Blake Windham; Martin T Woodlee; Timothy Schallert
Journal:  Behav Neurosci       Date:  2009-04       Impact factor: 1.912

8.  Research-based Updates in Swallowing and Communication Dysfunction in Parkinson Disease: Implications for Evaluation and Management.

Authors:  C K Broadfoot; D Abur; J D Hoffmeister; C E Stepp; M R Ciucci
Journal:  Perspect ASHA Spec Interest Groups       Date:  2019-10-11

9.  Lingual kinematics in dysarthric and nondysarthric speakers with Parkinson's disease.

Authors:  Min Ney Wong; Bruce E Murdoch; Brooke-Mai Whelan
Journal:  Parkinsons Dis       Date:  2011-10-09

10.  Effect of deep brain stimulation on speech performance in Parkinson's disease.

Authors:  Sabine Skodda
Journal:  Parkinsons Dis       Date:  2012-11-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.